Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Susan Fox MD, PhD

Susan H. Fox MD, PhD

Professor Neurology, University of Toronto, Krembil Brain Institute, UHN, Toronto, Ontario, Canada

Dr. Fox, MB, ChB, MRCP(UK), PhD, is Head of the Division of Neurology, University Health Network and Sinai Health Systems; holds the Krembil Family Chair of Neurology; Professor of Neurology, University of Toronto and Associate Director of the Movement Disorder Clinic, Toronto Western Hospital. Dr. Fox is chair-elect of the Pan-American section of the International Parkinson and Movement Disorder Society (MDS) (2021-23). She has served on committees, grant review and advisory boards for MDS, NIH, CIHR, Michael J Fox Foundation for Parkinson research and DMRF among others.   

Dr. Fox has over 20 years’ experience in preclinical models of Parkinson’s disease and translational studies of novel pharmacological therapies for Parkinson’s disease and other movement disorders such as dystonia. She has published over 170 peer-reviewed papers, reviews and book chapters in the field and is a regular speaker at national and international conferences.

Disclosures

Dr. Fox reports the following:
  • Clinic support from the Edmond J Safra Foundation for Parkinson Research; National Parkinson Foundation and the Toronto Western and General Foundation. Salary from UHN Dept of Medicine Practice Plan
  • Research Funding from Michael J Fox Foundation for Parkinson Research, NIH (Dystonia Coalition); CIHR; Parkinson Canada.
  • Honoraria from the International Parkinson and Movement Disorder Society and American Academy of Neurology
  • Site PI for Clinical Trials for Biotie, Cynapsus, Eisai, Revance.
  • Consultancy/Speaker fees from Acadia; Atuka; Sunovion; Teva; Paladin
  • Royalties from Oxford University Press